133 related articles for article (PubMed ID: 35001802)
1. Evaluation of central line salvage for mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) management practices in patients with hematologic malignancies.
El Boghdadly Z; Zhao Q; Koutou J; Lustberg ME; Ludwig M; Liscynesky C; Choe H
Leuk Lymphoma; 2022 Jun; 63(6):1455-1463. PubMed ID: 35001802
[TBL] [Abstract][Full Text] [Related]
2. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings.
Ardura MI; Bibart MJ; Mayer LC; Guinipero T; Stanek J; Olshefski RS; Auletta JJ
J Pediatr Hematol Oncol; 2021 Jan; 43(1):e64-e72. PubMed ID: 32960848
[TBL] [Abstract][Full Text] [Related]
3. The burden of mucosal barrier injury laboratory-confirmed bloodstream infection among hematology, oncology, and stem cell transplant patients.
Metzger KE; Rucker Y; Callaghan M; Churchill M; Jovanovic BD; Zembower TR; Bolon MK
Infect Control Hosp Epidemiol; 2015 Feb; 36(2):119-24. PubMed ID: 25632993
[TBL] [Abstract][Full Text] [Related]
4. Applying mucosal barrier injury laboratory-confirmed bloodstream infection criteria in patients with solid tumors and hematologic malignancies: A retrospective cohort study looking for the real source of infection.
Puin da Silva AC; Vieira MF; Freire MP; Vaz L; Bonazzi PR; Ibrahim KY; Diz MDPE; Hoff PM; Pereira J; Rocha VG; Abdala E
Infect Control Hosp Epidemiol; 2023 Feb; 44(2):302-304. PubMed ID: 35144717
[TBL] [Abstract][Full Text] [Related]
5. Impact of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) on central line-associated bloodstream infections (CLABSIs) in department of hematology at single university hospital in Japan.
Kato Y; Hagihara M; Kurumiya A; Takahashi T; Sakata M; Shibata Y; Kato H; Shiota A; Watanabe H; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jan; 24(1):31-35. PubMed ID: 29066217
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of catheter-related bloodstream infections in haemato-oncology patients: comparison of two definitions.
de Mooij CEM; van der Velden WJFM; Verweij PE; de Haan AFJ; van Groningen LFJ; Meijer C; Hopman J; Blijlevens NMA
J Hosp Infect; 2020 Aug; 105(4):686-690. PubMed ID: 32339616
[TBL] [Abstract][Full Text] [Related]
7. Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition.
See I; Iwamoto M; Allen-Bridson K; Horan T; Magill SS; Thompson ND
Infect Control Hosp Epidemiol; 2013 Aug; 34(8):769-76. PubMed ID: 23838215
[TBL] [Abstract][Full Text] [Related]
8. A Retrospective Analysis of Bloodstream Infections in Pediatric Allogeneic Stem Cell Transplant Recipients: The Role of Central Venous Catheters and Mucosal Barrier Injury.
Balian C; Garcia M; Ward J
J Pediatr Oncol Nurs; 2018 May; 35(3):210-217. PubMed ID: 29560765
[TBL] [Abstract][Full Text] [Related]
9. Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant.
Dandoy CE; Kim S; Chen M; Ahn KW; Ardura MI; Brown V; Chhabra S; Diaz MA; Dvorak C; Farhadfar N; Flagg A; Ganguly S; Hale GA; Hashmi SK; Hematti P; Martino R; Nishihori T; Nusrat R; Olsson RF; Rotz SJ; Sung AD; Perales MA; Lindemans CA; Komanduri KV; Riches ML
JAMA Netw Open; 2020 Jan; 3(1):e1918668. PubMed ID: 31913492
[TBL] [Abstract][Full Text] [Related]
10. Management of enterococcal central line-associated bloodstream infections in patients with cancer.
Awadh H; Chaftari AM; Khalil M; Fares J; Jiang Y; Deeba R; Ali S; Hachem R; Raad II
BMC Infect Dis; 2021 Jul; 21(1):643. PubMed ID: 34225651
[TBL] [Abstract][Full Text] [Related]
11. Which trial do we need? Scheduled central venous catheter removal vs. routine clinical care for prevention of central venous catheter-related bloodstream infections in patients with haematologic malignancies.
Schalk E; Panse J
Clin Microbiol Infect; 2023 Apr; 29(4):417-418. PubMed ID: 36639031
[No Abstract] [Full Text] [Related]
12. Central venous catheter salvage in children with Staphylococcus aureus central line-associated bloodstream infection.
Corkum KS; Jones RE; Reuter CH; Kociolek LK; Morgan E; Lautz TB
Pediatr Surg Int; 2017 Nov; 33(11):1201-1207. PubMed ID: 28948347
[TBL] [Abstract][Full Text] [Related]
13. Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell Transplantation.
Dandoy CE; Haslam D; Lane A; Jodele S; Demmel K; El-Bietar J; Flesch L; Myers KC; Pate A; Rotz S; Daniels P; Wallace G; Nelson A; Waters H; Connelly B; Davies SM
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1671-1677. PubMed ID: 27311966
[TBL] [Abstract][Full Text] [Related]
14. Chlorhexidine gluconate-coated gel pad dressings for prevention of central venous catheter-related bloodstream infections in patients with hematologic diseases or autologous stem cell transplantation: A registry-based matched-pair analysis.
Teschner D; Berisha M; Panse J; Schmitt T; Fiegle E; Naendrup JH; Neitz J; Schmidt-Hieber M; Hentrich M; Böll B; Schalk E
Eur J Haematol; 2023 Dec; 111(6):914-921. PubMed ID: 37705250
[TBL] [Abstract][Full Text] [Related]
15. Catheter-related infections in patients with acute type II intestinal failure admitted to a national centre: Incidence and outcomes.
Bond A; Teubner A; Taylor M; Cawley C; Varden J; Abraham A; Chadwick PR; Soop M; Carlson GL; Lal S
Clin Nutr; 2019 Aug; 38(4):1828-1832. PubMed ID: 30086999
[TBL] [Abstract][Full Text] [Related]
16. Central Venous Catheter Salvage in Ambulatory Central Line-Associated Bloodstream Infections.
Ford WJH; Bundy DG; Oyeku S; Heo M; Saiman L; Rosenberg RE; DeLaMora P; Rabin B; Zachariah P; Mirhaji P; Klein E; Obaro-Best O; Drasher M; Peshansky A; Rinke ML
Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34814175
[TBL] [Abstract][Full Text] [Related]
17. Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI): Descriptive Analysis of Data Reported to National Healthcare Safety Network (NHSN), 2013.
Epstein L; See I; Edwards JR; Magill SS; Thompson ND
Infect Control Hosp Epidemiol; 2016 Jan; 37(1):2-7. PubMed ID: 26456954
[TBL] [Abstract][Full Text] [Related]
18. Scheduled removal of central venous catheters (CVC) to prevent CVC-related bloodstream infections in patients with hematological disease or autologous stem cell transplantation: a registry-based randomized simulation-study.
Panse J; Tölle D; Fiegle E; Naendrup JH; Schmidt-Hieber M; Böll B; Hentrich M; Teschner D; Schalk E
Ann Hematol; 2022 Oct; 101(10):2317-2324. PubMed ID: 35978182
[TBL] [Abstract][Full Text] [Related]
19. Impact of removing mucosal barrier injury laboratory-confirmed bloodstream infections from central line-associated bloodstream infection rates in the National Healthcare Safety Network, 2014.
See I; Soe MM; Epstein L; Edwards JR; Magill SS; Thompson ND
Am J Infect Control; 2017 Mar; 45(3):321-323. PubMed ID: 27856070
[TBL] [Abstract][Full Text] [Related]
20. The Centers for Disease Control and Prevention definition of mucosal barrier injury-associated bloodstream infection improves accurate detection of preventable bacteremia rates at a pediatric cancer center in a low- to middle-income country.
Torres D; González ML; Loera A; Aguilera M; Relyea G; Aristizabal P; Caniza MA
Am J Infect Control; 2016 Apr; 44(4):432-7. PubMed ID: 26775931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
